Education
About Us
Working with TipRanks
Follow Us
Burt Adelman Insider Profile
4 Followers
Burt Adelman, CMO & EVP, R&D at Dyax Corp, holds 0.00 shares in Dyax Corp (Ticker: DYAX), holds ― shares in Astria Therapeutics (Ticker: ATXS), holds 0.00 shares in Verve Therapeutics (Ticker: VERV).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-20.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Burt Adelman holds in companies
Most Profitable Insider Trade
Stock:
Verve Therapeutics
(VERV)
(VERV)
Rating:Informative Buy
Date:May 13, 2022 - May 13, 2023
Return:+27.60%
The most profitable trade made by Burt Adelman
Burt Adelman's Trading History
Dyax Corp
Jan 22, 2016
―
Uninformative Sell
―
$0.00
Astria Therapeutics
―
Director
―
―
Verve Therapeutics
Jul 28, 2025
―
Uninformative Sell
―
$0.00
Biogen
―
EVP, Portfolio Strategy
―
$2.88M
List of latest transactions for each holding click on a transaction to see Burt Adelman's performance on stock
You May Also Like
Burt Adelman insider profile FAQ
What is the percentage of profitable transactions made by Burt Adelman?
The percentage of profitable transactions made by Burt Adelman is 25%.
What is the average return per transaction made by Burt Adelman?
The average return per transaction made by Burt Adelman is -20.60%.
What stocks does Burt Adelman hold?
Burt Adelman holds: DYAX, ATXS, VERV, BIIB stocks.
What was Burt Adelman’s latest transaction?
Burt Adelman latest transaction was an Uninformative Sell of ―.
What was Burt Adelman's most profitable transaction?
Burt Adelman’s most profitable transaction was an Informative Buy of VERV stock on May 13, 2022. The return on the trade was 27.60%.
What is Burt Adelman's role in Dyax Corp?
Burt Adelman's role in Dyax Corp is CMO & EVP, R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.